Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality compounded sterile preparations, continues to closely monitor the evolving COVID-19 situation and the potential healthcare drug shortages. Several Group Purchasing Organizations1 have recently surveyed their members and identified commonly used drugs that are in high demand and are close to, or are already, in a shortage. Here’s a list of some of the drugs that have specifically been referenced:
Dexmedetomidine, Ketamine, Midazolam
Hydromorphone, Fentanyl, Morphine
Leiters offers various presentations of these drugs (and others). As demand has rapidly increased, inventory is limited. We are currently shifting our production to the most critical and requested medications. If you are in need of these products (or others) please reach out to us at 800.292.6772 to check availability and/or secure your inventory today. We’ve been working with many hospitals, health systems and Group Purchasing Organizations to gather as much information as we can, however please contact us directly with your needs so we can plan accordingly.
We also want to make sure you have access to our current 503B Catalog. If you don't see something you're looking for or if you have questions, please call us at 800.292.6772 or email us at: firstname.lastname@example.org
We are inspired by and extremely grateful for everyone in the healthcare community around the country, working tirelessly to provide patient care and help the world navigate through today's challenges. We cannot thank you enough.
We stand ready to support your needs now and in the future. Please contact us today to see how we can help your facility. We will be providing ongoing updates through LinkedIn. Please be sure to follow us there for more information.
This post is related to:Admixture Compounding Services (503B Outsourcing Facilities) COVID-19